Literature DB >> 4607688

Cerebral reticulum cell sarcoma after multiple renal transplants.

L B Barnett, E Schwartz.   

Abstract

A case is reported of a 34 year old white male with chronic renal failure secondary to glomerulonephritis who received four renal transplants over a period of five years. He died 25 months after the fourth transplant. Necropsy revealed a reticulum cell sarcoma-microglioma of the brain. The possibility that multiple transplants may have had a synergistic effect in the development of a malignant cerebral lymphoma in this patient is briefly discussed in the light of the current theories concerning the pathogenesis of the tumours in transplant recipients and in the context of the present therapeutic approach to graft rejection.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4607688      PMCID: PMC494814          DOI: 10.1136/jnnp.37.8.966

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

1.  Risk of cancer in renal-transplant recipients.

Authors:  R Hoover; J F Fraumeni
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

2.  De-novo brain tumours in renal-transplant recipients.

Authors:  S A Schneck; I Penn
Journal:  Lancet       Date:  1971-05-15       Impact factor: 79.321

Review 3.  Malignant lymphoproliferative diseases: interactions between immunological abnormalities and oncogenic viruses.

Authors:  R S Schwartz; J André-Schwartz
Journal:  Annu Rev Med       Date:  1968       Impact factor: 13.739

4.  Lymphomatous leptomeningitis.

Authors:  J W Griffin; R W Thompson; M J Mitchinson; J C De Kiewiet; F H Welland
Journal:  Am J Med       Date:  1971-08       Impact factor: 4.965

5.  The immunologic capability of uremic patients.

Authors:  J P Merrill
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

Review 6.  Cellular immunity against tumor antigens.

Authors:  K E Hellström; I Hellström
Journal:  Adv Cancer Res       Date:  1969       Impact factor: 6.242

7.  Effect of azathioprine on the chromosome complement of human bone marrow cells.

Authors:  M K Jensen
Journal:  Int J Cancer       Date:  1970-01-15       Impact factor: 7.396

Review 8.  Malignancy as a complication of immunosuppressive therapy.

Authors:  S Leibowitz; R S Schwartz
Journal:  Adv Intern Med       Date:  1971

9.  Increased incidence of lymphoma after injections of mice with cells differing at weak histocompatibility loci.

Authors:  R L Walford
Journal:  Science       Date:  1966-04-01       Impact factor: 47.728

10.  Chronic allogeneic disease. II. Development of lymphomas.

Authors:  M Y Armstrong; E Gleichmann; H Gleichmann; L Beldotti; J Andre-Schwartz; R S Schwartz
Journal:  J Exp Med       Date:  1970-09-01       Impact factor: 14.307

View more
  7 in total

1.  Virus infections after transplantation in man. Brief review.

Authors:  M Ho
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

2.  Epstein-Barr virus and brain lymphomas.

Authors:  R M Bashir; F H Hochberg; M X Wei
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

3.  Reticulum cell sarcoma with unusual presenting features: fever and low cerebrospinal fluid glucose levels.

Authors:  M J Wong; R M Chan; S N Stordy
Journal:  Can Med Assoc J       Date:  1984-10-15       Impact factor: 8.262

4.  Primary malignant lymphoma of the CNS and polyneuropathy in a patient with necrotizing vasculitis treated with immunosuppression.

Authors:  K Jellinger; P Kothbauer; R Weiss; E Sunder-Plassmann
Journal:  J Neurol       Date:  1979-01-05       Impact factor: 4.849

5.  Involvement of the central nervous system in malignant lymphomas.

Authors:  K Jellinger; T Radiaszkiewicz
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-07-21

Review 6.  Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma.

Authors:  M Ponzoni; S Issa; T T Batchelor; J L Rubenstein
Journal:  Ann Oncol       Date:  2013-11-20       Impact factor: 32.976

7.  Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage.

Authors:  Genevieve M Crane; Helen Powell; Rumen Kostadinov; Patrick Tim Rocafort; Dena E Rifkin; Peter C Burger; Richard F Ambinder; Lode J Swinnen; Michael J Borowitz; Amy S Duffield
Journal:  Oncotarget       Date:  2015-10-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.